Physician
Behm, Frederick
Behm, Frederick was paid $32.29M by Medicaid between Jan 2018 and Jun 2023, across 336 billing codes. Its largest line is 87389, Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies — 9.1% of everything it billed.
33Billing provider infoBEHM, FREDERICK
CHICAGO, IL 60612
CHICAGO, IL 60612
33aNPI1457354656assigned 05/23/2005
33bProvider typeAnatomic Pathology Physician
28Total paid$32.29M
24GClaims3,663,458
24DCodes billed336
24AFirst – last monthJan 2018 – Jun 2023
Compared with peers
Next to other Anatomic Pathology Physician providers in Illinois
Rank by total paid#1 of 38
Median peer was paid$56K
This provider vs. median572×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 658,974 | $5.37M | |
| 2019 | 641,898 | $4.67M | |
| 2020 | 563,966 | $5.57M | |
| 2021 | 713,461 | $6.33M | |
| 2022 | 671,395 | $6.62M | |
| 2023 | 413,764 | $3.72M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 9.1% | 63,428 | 56,392 | $2.93M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 8.9% | 15,850 | 13,881 | $2.87M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5.1% | 67,088 | 60,454 | $1.63M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.0% | 66,845 | 60,265 | $1.63M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.8% | 26,088 | 20,591 | $1.56M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.6% | 34,559 | 27,337 | $1.17M |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.4% | 218,443 | 85,334 | $1.08M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.1% | 272,440 | 135,658 | $1000K |
| 80053 | Comprehensive metabolic panel | 2.9% | 164,391 | 104,151 | $950K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.5% | 25,502 | 18,782 | $794K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.4% | 49,708 | 44,538 | $784K |
| 82805 | 2.4% | 34,933 | 13,452 | $768K |
324 more codes
| 83735 | 2.2% | 174,670 | $708K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.6% | 56,010 | $527K |
| 85027 | 1.5% | 138,092 | $475K | |
| 86780 | 1.3% | 44,813 | $430K | |
| 86480 | 1.3% | 14,310 | $413K | |
| 87581 | 1.2% | 16,359 | $394K | |
| 87486 | 1.2% | 16,367 | $393K | |
| 84100 | 1.1% | 146,268 | $364K | |
| 87040 | 1.1% | 29,913 | $353K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.1% | 14,303 | $340K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 56,132 | $317K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 30,001 | $293K |
| 87536 | <1% | 6,125 | $270K | |
| 80076 | <1% | 55,046 | $260K | |
| 86803 | <1% | 27,204 | $248K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 8,220 | $239K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 58,244 | $226K |
| 80061 | Lipid panel | <1% | 53,261 | $219K |
| 82962 | <1% | 113,936 | $217K | |
| 83605 | <1% | 35,643 | $210K | |
| 82330 | <1% | 24,589 | $206K | |
| 85610 | <1% | 84,505 | $204K | |
| 85730 | <1% | 52,843 | $202K | |
| 83970 | <1% | 9,501 | $186K | |
| 87340 | <1% | 25,021 | $184K | |
| 87497 | <1% | 7,006 | $179K | |
| 84484 | <1% | 32,784 | $178K | |
| 87506 | <1% | 1,826 | $171K | |
| 87653 | <1% | 6,281 | $158K | |
| 86850 | <1% | 46,762 | $153K | |
| 87799 | <1% | 4,820 | $149K | |
| 87522 | Neg quan hep c or qual rna | <1% | 5,109 | $146K |
| 83880 | <1% | 11,123 | $144K | |
| 87641 | <1% | 5,710 | $140K | |
| 86901 | <1% | 52,386 | $134K | |
| 87088 | <1% | 22,092 | $131K | |
| 83655 | <1% | 19,352 | $130K | |
| 86832 | <1% | 1,412 | $127K | |
| 83615 | <1% | 37,629 | $126K | |
| 80197 | <1% | 19,076 | $122K | |
| 82728 | <1% | 21,859 | $118K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 7,402 | $114K |
| 86833 | <1% | 1,267 | $110K | |
| 82607 | <1% | 14,637 | $105K | |
| 86900 | <1% | 52,282 | $105K | |
| 87186 | <1% | 14,483 | $99K | |
| 81001 | <1% | 57,836 | $99K | |
| 86235 | <1% | 3,555 | $90K | |
| 83550 | <1% | 18,339 | $88K | |
| 84439 | <1% | 17,037 | $88K | |
| 83690 | <1% | 21,032 | $84K | |
| 86038 | <1% | 9,510 | $82K | |
| 86140 | <1% | 27,367 | $77K | |
| 86787 | <1% | 8,785 | $74K | |
| 82784 | <1% | 7,128 | $73K | |
| 82570 | <1% | 25,680 | $72K | |
| 86704 | <1% | 8,340 | $72K | |
| 83540 | <1% | 19,774 | $71K | |
| 85007 | <1% | 34,960 | $70K | |
| 86920 | <1% | 14,685 | $69K | |
| 87517 | <1% | 2,191 | $64K | |
| 87205 | <1% | 28,317 | $61K | |
| 82746 | <1% | 8,957 | $61K | |
| 82043 | <1% | 24,292 | $61K | |
| 85379 | <1% | 11,313 | $61K | |
| 82105 | <1% | 6,437 | $60K | |
| 84702 | <1% | 9,680 | $60K | |
| 85045 | <1% | 32,103 | $57K | |
| 84153 | <1% | 7,062 | $56K | |
| 86146 | <1% | 1,905 | $55K | |
| 83516 | <1% | 6,180 | $54K | |
| 87102 | <1% | 13,469 | $52K | |
| 84403 | <1% | 3,680 | $52K | |
| 86003 | <1% | 2,554 | $51K | |
| 86762 | <1% | 9,020 | $50K | |
| 86160 | <1% | 5,294 | $50K | |
| 86829 | <1% | 2,230 | $50K | |
| 85384 | <1% | 11,435 | $48K | |
| 87081 | <1% | 13,856 | $47K | |
| 80202 | <1% | 5,825 | $47K | |
| 87070 | <1% | 11,435 | $46K | |
| 83520 | <1% | 4,494 | $46K | |
| 86147 | <1% | 2,370 | $45K | |
| 83020 | <1% | 1,919 | $42K | |
| 86665 | <1% | 2,253 | $42K | |
| 86361 | <1% | 5,059 | $42K | |
| 86902 | <1% | 4,413 | $40K | |
| 83001 | <1% | 3,425 | $36K | |
| 82248 | <1% | 15,973 | $34K | |
| 82247 | <1% | 14,097 | $34K | |
| 84156 | <1% | 22,757 | $34K | |
| 84146 | <1% | 3,889 | $33K | |
| 86880 | <1% | 6,256 | $32K | |
| 81003 | <1% | 25,306 | $32K | |
| 85652 | <1% | 20,497 | $32K | |
| 87075 | <1% | 3,905 | $30K | |
| 80074 | <1% | 1,437 | $30K | |
| 84550 | <1% | 11,879 | $29K | |
| 86359 | <1% | 2,575 | $29K | |
| 87338 | <1% | 2,820 | $29K | |
| 82140 | <1% | 4,986 | $28K | |
| 86225 | <1% | 3,882 | $27K | |
| 83021 | <1% | 2,989 | $26K | |
| 82550 | <1% | 7,872 | $26K | |
| 86870 | <1% | 2,255 | $26K | |
| 86708 | <1% | 4,381 | $25K | |
| 87015 | <1% | 5,135 | $25K | |
| 80069 | <1% | 5,175 | $24K | |
| 87530 | <1% | 649 | $22K | |
| 82652 | <1% | 1,557 | $22K | |
| 82533 | <1% | 2,222 | $22K | |
| 85660 | <1% | 4,646 | $21K | |
| 86360 | <1% | 1,410 | $21K | |
| 86664 | <1% | 2,024 | $20K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,071 | $20K |
| 82670 | <1% | 2,250 | $19K | |
| 86663 | <1% | 2,058 | $19K | |
| 82150 | <1% | 4,907 | $19K | |
| 85598 | <1% | 2,042 | $18K | |
| 86694 | <1% | 2,234 | $18K | |
| 89051 | <1% | 4,943 | $18K | |
| 84270 | <1% | 1,852 | $18K | |
| 86644 | <1% | 2,144 | $18K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 757 | $18K |
| 86705 | <1% | 2,068 | $18K | |
| 82950 | <1% | 6,461 | $18K | |
| 86200 | <1% | 2,798 | $18K | |
| 84681 | <1% | 2,149 | $17K | |
| 82378 | <1% | 1,997 | $16K | |
| 84132 | <1% | 6,786 | $16K | |
| 84030 | <1% | 5,489 | $16K | |
| 84425 | <1% | 2,078 | $16K | |
| 83002 | <1% | 2,316 | $16K | |
| 86317 | <1% | 5,150 | $15K | |
| 87077 | <1% | 8,356 | $15K | |
| 82977 | <1% | 4,978 | $15K | |
| 86945 | <1% | 3,193 | $15K | |
| 86431 | <1% | 3,674 | $14K | |
| 87902 | <1% | 164 | $14K | |
| 82785 | <1% | 2,511 | $14K | |
| 80164 | <1% | 2,434 | $14K | |
| 84300 | <1% | 5,085 | $13K | |
| 86735 | <1% | 1,716 | $13K | |
| 86039 | <1% | 2,135 | $13K | |
| 87493 | <1% | 604 | $13K | |
| 81025 | <1% | 4,513 | $13K | |
| 87116 | <1% | 1,654 | $12K | |
| 83010 | <1% | 2,160 | $12K | |
| 87449 | <1% | 1,139 | $12K | |
| 82164 | <1% | 2,104 | $12K | |
| 86376 | <1% | 2,076 | $12K | |
| 83921 | <1% | 1,512 | $11K | |
| 81511 | <1% | 358 | $11K | |
| 85018 | <1% | 8,523 | $11K | |
| 86709 | <1% | 2,472 | $11K | |
| 84445 | <1% | 672 | $10K | |
| 84480 | <1% | 1,863 | $10K | |
| 84145 | <1% | 1,985 | $10K | |
| 86765 | <1% | 1,807 | $10K | |
| 82103 | <1% | 1,763 | $10K | |
| 86355 | <1% | 512 | $10K | |
| 86357 | <1% | 512 | $10K | |
| 82436 | <1% | 3,385 | $10K | |
| 83883 | <1% | 721 | $9K | |
| 84207 | <1% | 1,117 | $9K | |
| 82947 | <1% | 4,741 | $9K | |
| 86593 | <1% | 3,873 | $9K | |
| 86336 | <1% | 752 | $9K | |
| 84134 | <1% | 1,795 | $9K | |
| 84133 | <1% | 3,609 | $9K | |
| 82088 | <1% | 422 | $9K | |
| 82951 | <1% | 1,191 | $9K | |
| 84302 | <1% | 4,337 | $9K | |
| 83930 | <1% | 2,777 | $9K | |
| 87210 | <1% | 3,328 | $9K | |
| 83935 | <1% | 2,670 | $8K | |
| 87209 | <1% | 888 | $8K | |
| 83498 | <1% | 910 | $8K | |
| 82810 | <1% | 1,879 | $8K | |
| 86800 | <1% | 961 | $8K | |
| 84630 | <1% | 1,292 | $8K | |
| 82390 | <1% | 1,400 | $7K | |
| 84160 | <1% | 3,665 | $7K | |
| 80177 | <1% | 1,218 | $7K | |
| 87430 | <1% | 837 | $7K | |
| 87529 | <1% | 291 | $7K | |
| 82525 | <1% | 1,097 | $7K | |
| 86592 | <1% | 2,989 | $7K | |
| 87147 | <1% | 1,597 | $7K | |
| 82553 | <1% | 1,226 | $6K | |
| 84163 | <1% | 927 | $6K | |
| 82945 | <1% | 3,119 | $6K | |
| 82040 | <1% | 2,796 | $6K | |
| 82565 | <1% | 2,140 | $6K | |
| 84157 | <1% | 3,584 | $6K | |
| 84478 | <1% | 2,715 | $6K | |
| 82677 | <1% | 716 | $5K | |
| 84460 | <1% | 2,399 | $5K | |
| 86860 | <1% | 573 | $5K | |
| 84481 | <1% | 866 | $5K | |
| 83993 | <1% | 727 | $5K | |
| 84703 | <1% | 1,275 | $5K | |
| 82627 | <1% | 800 | $5K | |
| 84244 | <1% | 415 | $5K | |
| 82747 | <1% | 572 | $4K | |
| 85060 | <1% | 340 | $4K | |
| 87177 | <1% | 881 | $4K | |
| 84540 | <1% | 1,782 | $4K | |
| 86304 | <1% | 356 | $4K | |
| 87206 | <1% | 1,317 | $4K | |
| 84450 | <1% | 1,632 | $4K | |
| 82010 | <1% | 1,291 | $4K | |
| 84305 | <1% | 336 | $3K | |
| 87106 | <1% | 2,176 | $3K | |
| 84436 | <1% | 800 | $3K | |
| 80185 | <1% | 290 | $3K | |
| 85549 | <1% | 520 | $3K | |
| 86318 | <1% | 140 | $3K | |
| 86769 | <1% | 102 | $3K | |
| 82270 | <1% | 1,694 | $3K | |
| 81596 | <1% | 139 | $3K | |
| 86301 | <1% | 230 | $3K | |
| 87254 | <1% | 386 | $2K | |
| 85014 | <1% | 1,861 | $2K | |
| 84520 | <1% | 1,400 | $2K | |
| 85240 | <1% | 388 | $2K | |
| 84154 | <1% | 233 | $2K | |
| 86341 | <1% | 202 | $2K | |
| 84466 | <1% | 455 | $2K | |
| 82375 | <1% | 570 | $2K | |
| 85300 | <1% | 390 | $2K | |
| 84075 | <1% | 919 | $2K | |
| 82952 | <1% | 888 | $2K | |
| 80178 | <1% | 482 | $2K | |
| 82310 | <1% | 841 | $2K | |
| 85008 | <1% | 6,253 | $2K | |
| 80165 | <1% | 294 | $2K | |
| 87149 | <1% | 151 | $2K | |
| 82024 | <1% | 146 | $2K | |
| 85097 | <1% | 15 | $2K | |
| 83090 | <1% | 251 | $2K | |
| 81370 | <1% | 38 | $1K | |
| 80186 | <1% | 206 | $1K | |
| 84432 | <1% | 115 | $1K | |
| 82787 | <1% | 256 | $1K | |
| 87176 | <1% | 307 | $1K | |
| 80156 | <1% | 195 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 28 | $1K |
| 87385 | <1% | 155 | $1K | |
| 83718 | <1% | 452 | $1K | |
| 86777 | <1% | 136 | $1K | |
| 82139 | <1% | 169 | $1K | |
| 82465 | <1% | 704 | $1K | |
| 82042 | <1% | 373 | $1K | |
| 86825 | <1% | 37 | $1K | |
| 82172 | <1% | 146 | $1K | |
| 83789 | <1% | 168 | $1K | |
| 87076 | <1% | 199 | $1K | |
| 82104 | <1% | 207 | $1K | |
| 86695 | <1% | 136 | $1K | |
| 86618 | <1% | 72 | $1K | |
| 82136 | <1% | 147 | $1K | |
| 87350 | <1% | 118 | $957.50 | |
| 85613 | <1% | 178 | $948.24 | |
| 80158 | <1% | 109 | $876.56 | |
| 86965 | <1% | 178 | $875.06 | |
| 83721 | <1% | 227 | $861.14 | |
| 80050 | General health panel | <1% | 86 | $861.03 |
| 86696 | <1% | 75 | $747.40 | |
| 85245 | <1% | 108 | $746.64 | |
| 82955 | <1% | 146 | $743.04 | |
| 87101 | <1% | 214 | $710.54 | |
| 87305 | <1% | 87 | $682.95 | |
| 87521 | Neg quan hep c or qual rna | <1% | 36 | $674.09 |
| 81376 | <1% | 42 | $635.10 | |
| 82017 | <1% | 55 | $629.67 | |
| 84479 | <1% | 162 | $596.21 | |
| 84446 | <1% | 101 | $593.76 | |
| 83835 | <1% | 77 | $530.09 | |
| 87535 | <1% | 20 | $526.70 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 43 | $512.30 |
| 82610 | <1% | 88 | $489.28 | |
| 86682 | <1% | 76 | $463.25 | |
| 86707 | <1% | 63 | $430.43 | |
| 85247 | <1% | 59 | $409.46 | |
| 85246 | <1% | 59 | $405.92 | |
| 83519 | <1% | 43 | $402.60 | |
| 85306 | <1% | 60 | $362.70 | |
| 80175 | <1% | 51 | $341.70 | |
| 86403 | <1% | 97 | $340.14 | |
| 86141 | <1% | 34 | $321.00 | |
| 84080 | <1% | 44 | $311.01 | |
| 82379 | <1% | 40 | $251.14 | |
| 86703 | <1% | 118 | $236.11 | |
| 85049 | <1% | 83 | $225.59 | |
| 83525 | <1% | 45 | $221.50 | |
| 80170 | <1% | 39 | $211.13 | |
| 86778 | <1% | 19 | $178.60 | |
| 87899 | <1% | 34 | $177.84 | |
| 85303 | <1% | 29 | $175.50 | |
| 82232 | <1% | 30 | $163.18 | |
| 81229 | <1% | 12 | $131.40 | |
| 80201 | <1% | 17 | $124.55 | |
| 84999 | <1% | 55 | $116.30 | |
| 86701 | <1% | 16 | $103.68 | |
| 87181 | <1% | 22 | $102.30 | |
| 86702 | <1% | 16 | $81.60 | |
| 82340 | <1% | 27 | $77.16 | |
| 85520 | <1% | 12 | $72.88 | |
| 82009 | <1% | 32 | $72.85 | |
| 87184 | <1% | 12 | $72.00 | |
| 83527 | <1% | 16 | $70.88 | |
| 82595 | <1% | 19 | $61.13 | |
| 82085 | <1% | 14 | $44.10 | |
| 80353 | 0% | 124 | $0.00 | |
| 80349 | 0% | 275 | $0.00 | |
| 80320 | 0% | 1,612 | $0.00 | |
| 80358 | 0% | 14 | $0.00 | |
| 80359 | 0% | 12 | $0.00 | |
| 80348 | 0% | 277 | $0.00 | |
| 80354 | 0% | 298 | $0.00 | |
| 80365 | 0% | 425 | $0.00 | |
| 80323 | 0% | 203 | $0.00 | |
| 80321 | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.